(Q33569506)

28 July 2017

1 reference

title

Low molecular weight versus unfractionated heparin. A clinical and economic appraisal (English)

1 reference

28 July 2017

Heaton D

1

1 reference

28 July 2017

Pearce M

series ordinal

2

1 reference

28 July 2017

publication date

1 August 1995

1 reference

28 July 2017

1 reference

28 July 2017

volume

8

1 reference

28 July 2017

issue

2

1 reference

28 July 2017

page(s)

91-99

1 reference

Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis

28 July 2017

cites work

1 reference

12 December 2020

Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis

1 reference

12 December 2020

Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial

1 reference

12 December 2020

Comparison of efficacy and safety of low molecular weight heparins and unfractionated heparin in initial treatment of deep venous thrombosis: a meta-analysis

1 reference

12 December 2020

Low molecular weight heparin

1 reference

12 December 2020

Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin iii and by gel filtration

1 reference

12 December 2020

Prevention of venous thromboembolism after major abdominal surgery

1 reference

12 December 2020

Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group

1 reference

12 December 2020

Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery

1 reference

12 December 2020

Randomized trial of subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonary embolism. A dose-ranging study

1 reference

12 December 2020

Cost effectiveness and ease of administration of low molecular weight heparin in deep vein thrombosis

1 reference

12 December 2020

The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits

1 reference

12 December 2020

Efficacy and cost of low-molecular-weight heparin compared with standard heparin for the prevention of deep vein thrombosis after total hip arthroplasty

1 reference

12 December 2020

Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial

1 reference

12 December 2020

Comparative pharmacokinetics of a low molecular weight heparin (PK 10 169) and unfractionated heparin after intravenous and subcutaneous administration

1 reference

12 December 2020

Low molecular weight heparin: a critical analysis of clinical trials

1 reference

12 December 2020

Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis

1 reference

12 December 2020

Heparin-induced thrombocytopenia: studies with a new low molecular weight heparinoid, Org 10172.

1 reference

12 December 2020

Cost-benefit analysis of prophylaxis against deep vein thrombosis in surgery

1 reference

12 December 2020

Subcutaneous low molecular weight heparin versus subcutaneous unfractionated heparin in the treatment of deep vein thrombosis: a Polish multicenter trial

1 reference

12 December 2020

Acenocoumarol and heparin compared with acenocoumarol alone in the initial treatment of proximal-vein thrombosis

1 reference

12 December 2020

Comparison of the cost-effectiveness of administering heparin subcutaneously or intravenously for the treatment of deep vein thrombosis.

1 reference

12 December 2020

Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4.

1 reference

12 December 2020

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

12 December 2020

A cost-effectiveness analysis of prophylaxis against deep-vein thrombosis in major orthopedic surgery

1 reference

12 December 2020

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

12 December 2020

Low molecular weight heparin in prevention of perioperative thrombosis

1 reference

12 December 2020

Cost/benefit aspects on thromboprophylaxis

1 reference

12 December 2020

10.2165/00019053-199508020-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1048221669

0 references

1 reference